PPP1R12A and neoplasm: CD44 can activate MYPT1 (myosin phosphatase targeting subunit 1), which acts in opposition to the functions of CPI-17 (protein kinase C-potentiated phosphatase inhibitor of 17 kDa) [200] The activated MYPT1 then leads to a “closed” active merlin, resulting in tumor suppression.